查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2120472

實驗室機械臂：市場佔有率分析、產業趨勢與統計、成長預測（2026-2031）

Robotic Arms In Laboratories - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
出版日期: | 出版商: Mordor Intelligence | 英文 127 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

根據 Mordor Intelligence 預測，實驗室機械臂的市場規模預計將從 2025 年的 26.4 億美元成長到 2026 年的 27.9 億美元，到 2031 年將達到 37 億美元，2026 年至 2031 年的複合年成長率為 5.81%。

實驗室中的機械手臂-市場-IMG1

本報告按機械臂類型（多關節臂、雙臂、並聯臂及其他）、應用領域（藥物研發、數位成像及其他）、有效載荷能力（5公斤以下、5-15公斤、15公斤以上）、最終用戶（製藥和生物技術公司、學術研究機構及其他）以及地區進行細分。市場預測以美元計價。

全球實驗室機械臂市場趨勢及洞察

對高效能篩檢日益成長的需求正在推動小型化和速度提升。

目前，藥物研發流程宣傳活動需要處理 10 萬至 100 萬種化合物，如此龐大的數量使得人工移液難以持續。羅氏公司於 2024 年推出的 uMed 聲波液體處理系統，將亞納升級的液體分裝與機器視覺檢測相結合，可減少 40% 的試劑用量，並利用多關節機械臂實現 384孔盤的全自動處理。美國食品藥物管理局(FDA) 的 2024 年策略計畫指出，自動化、高性能篩檢對於加速臨床實驗藥物的申報至關重要，並鼓勵實驗室投資於符合審計要求的機器人。公共機構也紛紛效仿；美國國立衛生研究院 (NIH) 的轉化科學中心目前正在使用一條機器人生產線，每天測試 1 萬種化合物，這表明，如果資金充足，學術研究機構也能達到商業化水平的處理能力。因此，用於支援高性能篩檢的實驗室機械臂的市場引入在商業和學術領域持續成長。

協作機器人的廣泛應用將改變潔淨室的使用方式。

協作式機械臂使技術人員能夠安全地與機器人並肩工作，無需使用完整的安全籠。這項優勢節省了占地面積，並將安裝成本降低了約 40%。電裝 Wave 的「COBOTTA PRO」於 2025 年 1 月發布，其接觸壓力可達 10 牛頓，符合 ISO/TS 15066 的力限制標準，目前正被亞洲各地的製藥無塵室迅速採用。優傲機器人 (Universal Robots) 的「UR20」已安裝在 200 多個製藥生產基地，面積僅為 245 毫米，卻能舉起 20 公斤的重物，從而釋放了寶貴的工作空間。歐洲「附件 1」無菌指南和修訂後的 ISO/TS 標準將驗證週期從 18 個月縮短至 12 個月或更短，加速了義大利和德國灌裝包裝廠的採用。這些安全性和合規性的提升為協作式機器人 7.56% 的複合年成長率奠定了基礎，並進一步增強了實驗室機械臂市場的成長勢頭。

對符合 ISO 標準的機器人工作站而言，高昂的初始投資阻礙了學術機構的採用。

一台符合ISO 17025標準的無塵室六軸機械手臂通常售價超過30萬美元，而服務合約每年還要額外增加12%至15%的成本。依賴三年期NIH R01津貼的學術實驗室難以撥付如此巨額的資金，因此往往更傾向於採用人工操作流程。此外，ISO 15189認證要求每半年進行一次重量法校準，每次校準費用高達1.2萬美元，並且需要技術人員耗費約60小時。占美國新創企業70%的小規模生技公司缺乏足夠的資金將檢測工作外包給合約研究組織（CRO）。 「地平線歐洲」津貼要求30%至40%的成本分攤，這減緩了南歐和東歐成員國購買協作機器人的速度。這些經濟障礙持續限制實驗室機械臂市場的短期普及。

細分市場分析

到2025年，關節型機器人系統將佔據實驗室機械臂市場40.58%的佔有率，這得益於其亞50微米的精度和六自由度性能，使其適用於微孔盤處理。雙臂機器人仍屬於小眾技術，可實現並行操作，並將篩檢週期縮短高達30%。並行連桿結構在大型診斷實驗室的管瓶封蓋任務中，尤其擅長高速取放作業。協作機器人成長最快，年複合成長率達7.33%，這主要得益於製造商對無籠式ISO 7級和8級無塵室的維修。發那科（FANUC）的CRX單元可在偵測附近工作人員的同時完成條碼掃描和封條移除等流程，符合機械指令的限制。在工業領域，計劃於2026年修訂的IEC 61010-2-061標準預計將明確安全標準，並進一步加速該標準在協作機器人領域的應用。在實驗室機械臂市場中，預計到 2028 年，協作機器人的市場規模將超過關節平台。

協作機器人正日益普及，因為它們能降低約 40% 的安裝成本，縮短試運行週期，並能適應不斷變化的工作流程。製藥廠正朝著個人化醫療的方向發展，因此非常重視能在數小時內重新部署的協作機器人。安川馬達的 HC 系列透過整合機器視覺來區分人手和實驗室設備，從而避免夾傷事故。科研津貼有限的大學優先考慮示教器操作的便利性，因此像 Opentrons 的 OT-2 這樣的輕型機器人更受青睞。這些趨勢清晰地表明，協作設計如今已成為更廣泛的實驗室機械臂市場中各廠商藍圖的核心。

預計到2025年，藥物研發領域將佔銷售額的32.35%，但如今基因組學和蛋白​​質組學領域對樣品製備的需求已超過這一比例，複合年成長率高達6.86%。像Illumina的NovaSeq X Plus這樣的定序儀需要機器人來運送384孔盤，這些機器人可在90分鐘內完成熱處理、磁珠純化和螢光測量等工序，從而減少80%的人工勞動。使用Orbitrap Astral設備的蛋白質體學實驗室利用機器人採集2µL的液體，避免了交叉污染。臨床診斷中心已在ISO 5級生物安全櫃中部署了類似的機械臂來處理呼吸道樣本，確保工作人員的安全。包括全切片組織病理學在內的數位影像技術，利用機械臂每小時可處理200張切片。系統生物學研究團隊正在使用機器人微流體技術培養類器官，以研究藥物代謝。總體而言，這些高精度任務正在擴大實驗室機械臂的市場規模，尤其是在基因組學和蛋白​​質組學設施中。

美國食品藥物管理局(FDA) 關於伴隨診斷的指南建議使用自動化檢體製備來降低分析前變異性。因此，力求獲得美國病理學家協會 (CAP) 認證的實驗室更傾向於選擇能夠產生電子審計日誌的系統。這項監管要求，加上基因組定序成本的下降，推動了基因組機器人市場兩位數的成長。供應商現在提供帶有預校準運動文件的樣品製備盒，使用戶更容易採用。隨著應用範圍的擴大，實驗室機械臂市場在多組體學科學領域的戰略地位正進一步鞏固。

區域分析

預計到2025年，北美將佔全球銷售額的34.05%，反映了波士頓、舊金山灣區和三角研究園區等生命科學中心的集中。美國國立衛生研究院（NIH）在2025財政年度撥款12億美元用於共用設備，資助協作機器人以支持轉化腫瘤學（癌症治療的臨床應用）計畫。加拿大國家研究委員會（NRC）推出了一項5000萬加元（3700萬美元）的“智慧實驗室舉措”，旨在將政府機構的生產力提高30%。墨西哥哈利斯科州和墨西哥城的製藥廠正在實施自動化管瓶填充流程，以符合美國現行藥品生產品質管理規範（cGMP），從而產生區域性連鎖反應。這些因素共同鞏固了北美在實驗室機械臂市場的主導地位。

預計到2025年，歐洲將佔據約27.82%的市場佔有率，這主要得益於設備升級，而設備升級又源於對無菌法規和數據完整性的日益重視（詳見附件1） 。英國已向弗朗西斯·克里克研究所和惠康桑格研究所津貼4,000萬英鎊（約5,100萬美元），用於基因組學自動化。德國弗勞恩霍夫網路於2024年引進了用於培養基製備的協作機器人，而義大利和西班牙已將無菌填充和精加工能力轉移回國內，以應對疫情造成的供應衝擊。這些投資確保了歐洲在協作安全標準方面保持領先地位，從而鞏固了全部區域實驗室機械臂市場的價值。

預計到2031年，亞太地區將以6.78%的複合年成長率成長，成為全球成長最快的地區。這主要得益於世界各國政府對生物安全實驗室和智慧製造試點計畫的投資。中國重點發展合成生物學，並撥款30億元人民幣（約4.2億美元）用於重點學術機構的機器人自動化建造。印度生物技術部啟動了一項1.5億美元的津貼，用於疫苗實驗室的現代化改造，以符合該國的疫苗自給自足目標。大型製藥企業正在利用協作機器人維修工廠，以應對人手不足。韓國已投資800億韓元（約6,000萬美元）興建其國家細胞治療中心。

同時，在以色列和海灣國家，診斷任務的自動化正在推進，以滿足醫療旅遊業的需求。雖然在非洲和南美洲仍處於早期應用階段，但南非和巴西的試點計畫表明，未來該技術具有廣泛應用的潛力。這些區域趨勢凸顯了亞太地區作為實驗室機械臂市場成長引擎的重要地位。

其他福利

  • Excel格式的市場預測（ME）表
  • 3個月的分析師支持

目錄

第1章：引言

  • 研究假設和市場定義
  • 調查範圍

第2章：調查方法

第3章執行摘要

第4章 市場狀況

  • 產業價值鏈分析
  • 監理情勢
  • 技術展望
  • 宏觀經濟因素對市場的影響
  • 波特五力分析
  • 市場促進因素
    • 對高性能篩檢的需求日益成長
    • 擴大協作機器人（cobot）的應用
    • 加強生物安全實驗室的職業安全法規
    • 製藥業向連續生產轉型
    • 檢體醫療的發展正在推動樣本製備的自動化。
    • 新興國家政府為發展智慧實驗室基礎設施提供補貼
  • 市場限制因素
    • 對符合 ISO 標準的機器人工作站而言，高昂的初始投資阻礙了學術機構的採用。
    • 我們處理精細、微量工作的能力有限。
    • 將傳統LIMS與ELN平台整合所面臨的挑戰
    • 學術實驗室缺乏熟練的機電一體化人員

第5章 市場規模與成長預測

  • 按臂型
    • 多關節臂
    • 雙臂
    • 平行連桿臂
    • 合作部門
    • 其他類型的手臂
  • 透過使用
    • 藥物發現
    • 月球成像
    • 基因組學和蛋白​​質組學
    • 臨床診斷
    • 系統生物學
    • 其他
  • 按有效載荷能力
    • 5公斤或以下
    • 5～15kg
    • 超過15公斤
  • 最終用戶
    • 製藥和生物技術公司
    • 學術研究機構
    • 臨床診斷實驗室
    • 受託研究機構
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 義大利
      • 其他歐洲國家
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 其他亞太國家
    • 中東
      • 以色列
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 土耳其
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 其他非洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭情勢

  • 市場集中度
  • 策略趨勢
  • 市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Hamilton Company
    • Hudson Robotics Inc.
    • Tecan Group Ltd.
    • Anton Paar GmbH
    • bioMerieux SA
    • Siemens Healthineers AG
    • Beckman Coulter Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Abbott Laboratories
    • Yaskawa Electric Corporation
    • FANUC Corporation
    • Kawasaki Heavy Industries Ltd.
    • Denso Wave Inc.
    • Universal Robots A/S
    • Precise Automation Inc.
    • Labman Automation Ltd.
    • Opentrons Labworks Inc.
    • Biosero Inc.

第7章 市場機會與未來展望

簡介目錄
Product Code: 47449

According to Mordor Intelligence, the robotic arms in laboratories market size is expected to grow from USD 2.64 billion in 2025 to USD 2.79 billion in 2026 and is forecast to reach USD 3.7 billion by 2031 at 5.81% CAGR over 2026-2031.

Robotic Arms In Laboratories - Market - IMG1

This report is Segmented by Type (Articulated Arm, Dual Arm, Parallel Link Arm, and More), Application (Drug Discovery, Digital Imaging, and More), Payload Capacity (Up To 5 Kg, 5 Kg To 15 Kg, and Above 15 Kg), End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Robotic Arms In Laboratories Market Trends and Insights

Escalating Demand for High-Throughput Screening Drives Miniaturization and Speed

Pharmaceutical discovery pipelines now process between 100,000 and 1 million compounds per campaign, volumes that make manual pipetting unsustainable. Roche's uMed acoustic liquid handler, launched in 2024, pairs sub-nanoliter dispensing with machine-vision inspection, trimming reagent use by 40% while enabling fully unattended 384-well plate shuttling by articulated robotic arms. The United States Food and Drug Administration's 2024 strategic plan recognizes automated high-throughput screening as critical for faster investigational new drug submissions, encouraging laboratories to invest in audit-ready robots. Public-sector facilities follow suit; the National Institutes of Health's translational sciences center now tests 10,000 compounds daily using robotic lines, demonstrating that academic labs can achieve commercial-grade throughput when adequately funded. As a result, robotic arms in laboratories market deployments that support high-throughput screening continue to climb across both commercial and academic sites.

Rising Adoption of Collaborative Laboratory Robots Reshapes Cleanrooms

Collaborative arms enable technicians to work safely alongside robots without full safety caging, a benefit that preserves floor space and reduces installation costs by approximately 40%. DENSO Wave's COBOTTA PRO, released in January 2025, achieves a contact pressure of 10 newtons, aligning with ISO/TS 15066 force limits and experiencing early uptake in Asian pharmaceutical cleanrooms. Wave's COBOTTA PRO, released in January 2025, achieves a contact pressure of 10 newtons, aligning with ISO/TS 15066 force limits and experiencing early uptake in Asian pharmaceutical cleanrooms. Universal Robots' UR20, already installed at over 200 drug-manufacturing sites, lifts 20 kg while occupying a 245 mm footprint, freeing valuable bench area. Europe's Annex 1 aseptic guidelines and the updated ISO/TS standard have trimmed validation times from 18 months to under 12, accelerating purchases in Italian and German fill-finish plants. These safety and compliance gains underpin the 7.56% CAGR for collaborative units, reinforcing growth momentum for the robotic arms in laboratories market.

High Upfront Capital Outlay for ISO-Compliant Robotic Cells Deters Academic Adopters

A six-axis arm with a cleanroom enclosure and ISO 17025 validation often exceeds USD 300,000, with service contracts adding 12-15% yearly. Academic labs relying on three-year NIH R01 grants struggle to allocate such funds, favoring manual workflows. ISO 15189 accreditation further mandates semi-annual gravimetric calibration, which costs up to USD 12,000 per cycle and approximately 60 technician hours. Small biotechnology firms, which form 70% of United States startups, lack capital reserves and instead outsource assays to contract research organizations. Horizon Europe grants require 30-40% cost sharing, slowing cobot purchases in Southern and Eastern member states. These financial barriers continue to temper near-term uptake within the robotic arms in laboratories market.

Other drivers and restraints analyzed in the detailed report include:

  1. Stricter Occupational Safety Mandates in Biosafety Labs Elevate Engineering Controls
  2. Pharmaceutical Shift Toward Continuous Manufacturing Demands Integrated Robots
  3. Integration Challenges with Legacy LIMS and ELN Platforms Fragment Data Workflows

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Articulated systems captured 40.58% of the robotic arms in laboratories market share in 2025, thanks to sub-50 µm repeatability and six-degree-of-freedom capabilities that suit microplate handling. Dual-arm robots remain a niche technology, but they enable parallel tasks, cutting the screening cycle time by up to 30%. Parallel-link architectures excel at rapid pick-and-place for vial capping in high-volume diagnostic labs. Collaborative designs recorded the fastest growth, expanding at 7.33% CAGR as manufacturers retrofit ISO Class 7 and 8 suites without cages. A FANUC CRX unit completes barcode scanning and seal-peel steps while sensing nearby staff, meeting Machinery Directive limits. The industry anticipates the forthcoming revision of IEC 61010-2-061 in 2026 to clarify safety criteria, thereby further enhancing the collaborative adoption of this standard. The robotic arms in laboratories market size for collaborative units is projected to surpass that of articulated platforms by 2028.

Collaborative arms thrive because they reduce installation costs by approximately 40%, compress commissioning schedules, and adapt to changing workflows. Pharmaceutical plants transitioning to personalized medicines value cobots that can be redeployed within hours. Yaskawa's HC-series integrates machine vision to distinguish between human hands and labware, thereby avoiding pinch points. Universities favor lightweight units, such as the Opentrons OT-2, for teach-pendant simplicity under constrained grant budgets. These dynamics underscore why collaborative designs now anchor vendor roadmaps inside the broader robotic arms in laboratories market.

Drug discovery dominated 32.35% revenue in 2025, but sample-prep loads in genomics and proteomics now outpace it, with an 6.86% CAGR. Sequencers like Illumina NovaSeq X Plus require robots that transfer 384-well plates through heating, bead cleanup, and fluorometric checks in under 90 minutes, slashing hands-on work by 80%.Proteomics labs running Orbitrap Astral instruments rely on robots for 2 µL pickups, eliminating carryover. Clinical diagnostics centers deploy similar arms in ISO Class 5 biosafety cabinets to process respiratory panels, maintaining operator safety. Digital imaging, including whole-slide histopathology, uses arms to load 200 slides per hour. Systems biology groups culture organoids with robotic microfluidics to study drug metabolism. Collectively, these high-precision tasks expand the market size of robotic arms in laboratories, particularly within genomics and proteomics facilities.

The United States Food and Drug Administration guidance on companion diagnostics encourages the use of automated preparation to reduce pre-analytical variance. Laboratories pursuing College of American Pathologists accreditation, therefore, favor systems that generate electronic audit logs. This regulatory pull, coupled with falling genome-sequencing costs, sustains double-digit growth for robots serving genomics workloads. Vendors now package library-prep kits with pre-calibrated motion files, making installation easier. As adoption broadens, the robotic arms in laboratories market reinforce their strategic role in multi-omic science.

Complete Report Scope:

  • By Arm Type
    • Articulated Arm
    • Dual Arm
    • Parallel Link Arm
    • Collaborative Arm
    • Other Arm Types
  • By Application
    • Drug Discovery
    • Digital Imaging
    • Genomics and Proteomics
    • Clinical Diagnostics
    • Systems Biology
    • Other Applications
  • By Payload Capacity
    • Up To 5 kg
    • 5 kg - 15 kg
    • Above 15 kg
  • By End-User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Clinical Diagnostics Laboratories
    • Contract Research Organizations
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia
    • Middle East
      • Israel
      • Saudi Arabia
      • United Arab Emirates
      • Turkey
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Rest of Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Geography Analysis

North America held 34.05% of the revenue in 2025, reflecting the concentration of life-science hubs in Boston, the San Francisco Bay Area, and Research Triangle Park. The National Institutes of Health set aside USD 1.2 billion for shared instrumentation in fiscal 2025, funding cobots that assist translational oncology projects. Canada's National Research Council launched a CAD 50 million (USD 37 million) Smart Lab Initiative targeting 30% productivity gains in government facilities. Mexico's pharmaceutical plants in Jalisco and Mexico City automate vial filling to comply with the United States' current Good Manufacturing Practice, illustrating regional spillover. Together, these factors strengthen North American dominance within the robotic arms in laboratories market.

Europe followed with around 27.82% share in 2025 as Annex 1 aseptic rules and data-integrity expectations spurred upgrades. The United Kingdom awarded GBP 40 million (USD 51 million) to the Francis Crick and Wellcome Sanger institutes for genomics automation. Germany's Fraunhofer network installed cobots for media prep in 2024, while Italy and Spain onshored sterile fill-finish capacity in response to pandemic supply shocks. These investments keep Europe at the forefront of collaborative safety standards and validate the robotic arms in laboratories market across the region.

The Asia Pacific is projected to grow at a 6.78% CAGR through 2031, the fastest worldwide, as governments invest in biosafety labs and smart-manufacturing pilots. China earmarked CNY 3 billion (USD 420 million) for robotic automation at top academies, focusing on synthetic biology. India's Department of Biotechnology has launched a USD 150 million grant to modernize vaccine labs, aligning with the country's self-reliance goals. Japan's pharmaceutical majors are retrofitting plants with cobots to offset labor shortages, and South Korea has invested KRW 80 billion (USD 60 million) in a national cell-therapy center.

Meanwhile, Israel and Gulf states are automating diagnostics to serve the medical tourism industry. Although Africa and South America remain nascent, pilots in South Africa and Brazil hint at future uptake. These regional dynamics underline the Asia Pacific's role as the growth engine for robotic arms in laboratories market.

List of Companies Covered in this Report:

  1. Thermo Fisher Scientific Inc.
  2. Hamilton Company
  3. Hudson Robotics Inc.
  4. Tecan Group Ltd.
  5. Anton Paar GmbH
  6. bioMerieux SA
  7. Siemens Healthineers AG
  8. Beckman Coulter Inc.
  9. PerkinElmer Inc.
  10. QIAGEN NV
  11. Abbott Laboratories
  12. Yaskawa Electric Corporation
  13. FANUC Corporation
  14. Kawasaki Heavy Industries Ltd.
  15. Denso Wave Inc.
  16. Universal Robots A/S
  17. Precise Automation Inc.
  18. Labman Automation Ltd.
  19. Opentrons Labworks Inc.
  20. Biosero Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

  • 4.1 Industry Value-Chain Analysis
  • 4.2 Regulatory Landscape
  • 4.3 Technological Outlook
  • 4.4 Impact of Macroeconomic Factors on the Market
  • 4.5 Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Intensity of Competitive Rivalry
  • 4.6 Market Drivers
    • 4.6.1 Escalating Demand for High-Throughput Screening
    • 4.6.2 Rising Adoption of Collaborative Laboratory Robots (Cobots)
    • 4.6.3 Stricter Occupational Safety Mandates in Biosafety Labs
    • 4.6.4 Pharmaceutical Shift Toward Continuous Manufacturing
    • 4.6.5 Growth of Precision Medicine Driving Sample-Prep Automation
    • 4.6.6 Emerging Government Grants for Smart Lab Infrastructure
  • 4.7 Market Restraints
    • 4.7.1 High Upfront Capital Outlay for ISO-Compliant Robotic Cells
    • 4.7.2 Limited Dexterity in Handling Fragile Micro-volume Tasks
    • 4.7.3 Integration Challenges with Legacy LIMS and ELN Platforms
    • 4.7.4 Scarcity of Skilled Mechatronics Personnel in Academic Labs

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Arm Type
    • 5.1.1 Articulated Arm
    • 5.1.2 Dual Arm
    • 5.1.3 Parallel Link Arm
    • 5.1.4 Collaborative Arm
    • 5.1.5 Other Arm Types
  • 5.2 By Application
    • 5.2.1 Drug Discovery
    • 5.2.2 Digital Imaging
    • 5.2.3 Genomics and Proteomics
    • 5.2.4 Clinical Diagnostics
    • 5.2.5 Systems Biology
    • 5.2.6 Other Applications
  • 5.3 By Payload Capacity
    • 5.3.1 Up To 5 kg
    • 5.3.2 5 kg - 15 kg
    • 5.3.3 Above 15 kg
  • 5.4 By End-User
    • 5.4.1 Pharmaceutical and Biotechnology Companies
    • 5.4.2 Academic and Research Institutes
    • 5.4.3 Clinical Diagnostics Laboratories
    • 5.4.4 Contract Research Organizations
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 United Kingdom
      • 5.5.2.2 Germany
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 South Korea
      • 5.5.3.5 Rest of Asia
    • 5.5.4 Middle East
      • 5.5.4.1 Israel
      • 5.5.4.2 Saudi Arabia
      • 5.5.4.3 United Arab Emirates
      • 5.5.4.4 Turkey
      • 5.5.4.5 Rest of Middle East
    • 5.5.5 Africa
      • 5.5.5.1 South Africa
      • 5.5.5.2 Egypt
      • 5.5.5.3 Rest of Africa
    • 5.5.6 South America
      • 5.5.6.1 Brazil
      • 5.5.6.2 Argentina
      • 5.5.6.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (Includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Thermo Fisher Scientific Inc.
    • 6.4.2 Hamilton Company
    • 6.4.3 Hudson Robotics Inc.
    • 6.4.4 Tecan Group Ltd.
    • 6.4.5 Anton Paar GmbH
    • 6.4.6 bioMerieux SA
    • 6.4.7 Siemens Healthineers AG
    • 6.4.8 Beckman Coulter Inc.
    • 6.4.9 PerkinElmer Inc.
    • 6.4.10 QIAGEN NV
    • 6.4.11 Abbott Laboratories
    • 6.4.12 Yaskawa Electric Corporation
    • 6.4.13 FANUC Corporation
    • 6.4.14 Kawasaki Heavy Industries Ltd.
    • 6.4.15 Denso Wave Inc.
    • 6.4.16 Universal Robots A/S
    • 6.4.17 Precise Automation Inc.
    • 6.4.18 Labman Automation Ltd.
    • 6.4.19 Opentrons Labworks Inc.
    • 6.4.20 Biosero Inc.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

  • 7.1 White-Space and Unmet-Need Assessment